PMC · DOI:10.3389/fphar.2026.1787363·January 28, 2026
Editorial: Advancement of RWD/RWE utilization for enhancing drug development and benefit/risk assessment
Yoshiaki Uyama, Anick Bérard, K. Arnold Chan
Abstract
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmacovigilance and Adverse Drug Reactions · Advanced Causal Inference Techniques · Statistical Methods in Clinical Trials